Utama › Kanser Pundi Kencing › Pennsylvania › Philadelphia
Kajian klinikal Kanser Pundi Kencing di Philadelphia, PA
21 kajian untuk Kanser Pundi Kencing sedang mencari peserta di lokasi dalam dan sekitar Philadelphia (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Mengambil pesertaFasa 3
- Fox Chase Cancer Center, Philadelphia
- Fox Chase Cancer Center-Rockledge, Rockledge · 10 mi jauh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi jauh
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Mengambil pesertaFasa 2
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi jauh
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Mengambil pesertaFasa 2
- MidLantic Urology ( Site 0102), Bala-Cynwyd · 5 mi jauh
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Mengambil pesertaFasa 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi jauh
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
DESTINY-PANTUMOUR04
Mengambil pesertaKajian pemerhatian
- Research Site, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Mengambil peserta
- Fox Chase Cancer Center - Philadelphia, Philadelphia
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Mengambil pesertaFasa 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Mengambil pesertaKajian pemerhatian
- University of Pennsylvania, Philadelphia
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Mengambil pesertaFasa 2
- University of Pennsylvania, Philadelphia
- Midlantic Urology (Solaris), Bala-Cynwyd · 5 mi jauh
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Mengambil pesertaFasa 1
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Mengambil pesertaFasa 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi jauh
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi jauh
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Mengambil pesertaFasa 1/2
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Mengambil pesertaFasa 2
- Thomas Jefferson University, Philadelphia
Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
Mengambil pesertaFasa 1
- University of Pennsylvania, Philadelphia
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
Mengambil peserta
- Abramson Cancer Center, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- University of Pennsylvania, Philadelphia
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Mengambil peserta
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Einstein Philadelphia Hospital, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Mengambil pesertaFasa 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Philadelphia
Kajian Kanser Pundi Kencing di bandar lain
- New York City, NY35 kajian
- Nashville, TN31 kajian
- Houston, TX31 kajian
- Dallas, TX27 kajian
- Boston, MA26 kajian
- Washington, DC26 kajian
- Los Angeles, CA24 kajian
- Baltimore, MD24 kajian
- St. Louis, MO22 kajian
- Seattle, WA21 kajian
- Edison, NJ21 kajian
- Chicago, IL21 kajian
Kajian lain di Philadelphia
- Kanser (semua jenis)59 kajian
- Kanser Payudara56 kajian
- Kanser Paru-paru Bukan Sel Kecil51 kajian
- Kanser Metastatik46 kajian
- Kanser Kolorektal44 kajian
- Kanser Ovari44 kajian
- Kanser Prostat44 kajian
- Kanser Paru-paru36 kajian
- Leukemia Mieloid Akut34 kajian
- Kegagalan Jantung31 kajian
- Kanser Endometrium28 kajian
- Depresi26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.